semaglutide black box label These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 Semaglutide | NextGenRx Compound Pharmacy

CV outcomes data Retatrutide Highest weight loss in early data These compounds are not interchangeable

Handling the half-unit challenge Most standard insulin syringes do not have half-unit markings

Spoorthy MS, Chakrabarti S, Grover S

The advertising strategy is part of a broader pattern

It was initially thought that the anti-diabetic effects of DPP-4 inhibition were predominantly due to the enhanced levels of intact GLP-1 [because the insulinotropic effect of GIP is substantially impaired in subjects with T2DM (42)], but this now seems not to be the case

Others may not realise that over a quarter of a billion rare disease sufferers in this World are currently receiving little or no appropriate treatment for the conditions they suffer from